Tianming Cui
Impact in
-
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
Papers in
- Oncology 4
- Cancer Immunotherapy and Biomarkers 3
- Colorectal Cancer Treatments and Studies 1
-
- RNA modifications and cancer 2
- Co-authors
- Yao Liu (6 shared papers)Lianxin Liu (1 shared paper)Jiabei Wang (7 shared papers)Lianxin Liu (7 shared papers)Linmao Sun (6 shared papers)Xinyu Guo (4 shared papers)Shuo Zhou (4 shared papers)Xianying Li (4 shared papers)
- Journals
- Cancer Letters (1 paper)Nature Communications (1 paper)eLife (1 paper)OncoTargets and Therapy (1 paper)Advanced Science (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Tianming Cui
8 papers receiving 104 citations
Peers
Comparison fields: 5 of 31
- Hepatology 30
- Cancer Research 33
- Oncology 39
- Biochemistry 8
- Immunology 20
Countries citing papers authored by Tianming Cui
This map shows the geographic impact of Tianming Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianming Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianming Cui more than expected).
Fields of papers citing papers by Tianming Cui
This network shows the impact of papers produced by Tianming Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianming Cui. The network helps show where Tianming Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Tianming Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 35 | |
| 2 | 2022 | 18 | |
| 3 | 2024 | 14 | |
| 4 | 2024 | 12 | |
| 5 | 2024 | 12 | |
| 6 | 2024 | 9 | |
| 7 | 2025 | 2 | |
| 8 | 2024 | 2 |
About Tianming Cui
Tianming Cui is a scholar working on Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Immunology, having authored 8 papers that have together received 104 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Cancer, Lipids, and Metabolism (2 papers), RNA modifications and cancer (2 papers), Ferroptosis and cancer prognosis (2 papers), Immune cells in cancer (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Hepatology (30 citations), Cancer Research (33 citations), Oncology (39 citations), Biochemistry (8 citations) and Immunology (20 citations). Tianming Cui has collaborated with scholars based in China and United States. Frequent co-authors include Yao Liu, Lianxin Liu, Jiabei Wang, Lianxin Liu, Linmao Sun, Xinyu Guo, Shuo Zhou, Xianying Li, Ning Zhang and Yufeng Liu. Their work appears in journals such as Cancer Letters, Nature Communications, eLife, OncoTargets and Therapy and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.